CATX
Perspective Therapeutics, Inc. · Healthcare · Market cap $357.3M
Insiders sold $1.6M net in the last 90 days ·2 sellers, 0 buyers· latest Form 4 filed Sep 8, 2026
Insider Buying
$42K
reported purchases (SEC code P)
Insider Selling
$1.6M
reported sales (SEC code S)
Unique Insiders
4
in the rolling window
Latest filing
Sep 8, 2026
Lantheus Alpha Therapy, LLC
Perspective Therapeutics, Inc. (CATX) has 7 SEC Form 4 filings (9 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Sep 8, 2026.
Inside the rolling window, 4 insiders at Perspective Therapeutics, Inc. reported 2 open-market purchases totaling $42K and 7 open-market sales totaling $1.6M. The most active filer is 10% Owner Lantheus Alpha Therapy, LLC with 5 filings. Insiders have net sold $1.6M over the trailing 6 months. The most recent open-market filing is a sale of 80,783 shares by 10% Owner Lantheus Alpha Therapy, LLC, dated Sep 3, 2026, worth $251K.
- Industry:Medical - Devices
- CEO:Johan Spoor
- Employees:165
- HQ:Seattle, WA, US
- IPO:2005-11-10
| Source | |||||||
|---|---|---|---|---|---|---|---|
| 10% Owner | Sale | 80,783 | $251K | Sep 8 | — | SEC ↗ | |
| 10% Owner | Sale | 167,149 | $526K | Sep 8 | — | SEC ↗ | |
| 10% Owner | Sale | 78,145 | $246K | Sep 4 | — | SEC ↗ | |
| 10% Owner | Sale | 35,769 | $112K | Sep 4 | — | SEC ↗ | |
Lantheus Alpha Therapy, LLCFirst filing | 10% Owner | Sale | 42,129 | $131K | Sep 4 | — | SEC ↗ |
| 10% Owner | Sale | 35,769 | $112K | Sep 3 | +0.3% | SEC ↗ | |
Lantheus Holdings, Inc.First filing | 10% Owner | Sale | 78,145 | $246K | Sep 2 | +1.0% | SEC ↗ |
Hunt Jonathan RobertFirst filing | Chief Accounting Officer | Purchase | 11,000 | $22K | Nov 17 | +41.6% | SEC ↗ |
Williamson Robert F IIIFirst filing | Director | Purchase | 9,498 | $20K | Nov 14 | +50.5% | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does CATX have?
Perspective Therapeutics, Inc. (CATX) has 7 SEC Form 4 filings (9 transaction rows) in the rolling 365-day window, disclosed by 4 distinct insiders. Most recent filing: Sep 8, 2026.
When was the most recent SEC Form 4 filing for CATX?
The most recent Form 4 filing for CATX on Tracefour is dated Sep 8, 2026.
Who is the most active insider at CATX?
The most active SEC Form 4 filer at CATX in the rolling window is 10% Owner Lantheus Alpha Therapy, LLC, with 5 filings.
What is the net insider flow at CATX over the last 6 months?
Over the trailing 180 days, insiders at CATX have net sold $1.6M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at CATX in the current window?
Inside the rolling window, insiders at CATX bought $42K and sold $1.6M based on SEC Form 4 filings.
Can I get alerts for CATX insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Perspective Therapeutics, Inc. (CATX). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Perspective Therapeutics, Inc. is in the Healthcare sector.